Electroceuticals Bioelectric Medicine Market Share, Size 2022 Global Industry Analysis by Trends, Demand, Technology Progress, Company Overview, Growth and Forecast by 2029 [MarketWatch]
Nevro Corp. (NVRO)
Last nevro corp. earnings: 2/25 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
nevro.com/english/investors/overview/default.aspx
Company Research
Source: MarketWatch
The MarketWatch News Department was not involved in the creation of this content. Jan 25, 2022 (The Expresswire) -- Global “ Electroceuticals Bioelectric Medicine Market ” research report covers the market landscape and growth prospect over the coming years, this report covers the industry structure the problems along with business strategies and industry effectiveness. Report study provides critical information related to the global, regional, and top players including Electroceuticals Bioelectric Medicine market share analysis, winning strategies, recent developments, and financials. The purpose of the Electroceuticals Bioelectric Medicine market report is to support beginner as well as existing players in gaining insightful and make appropriate decisions based on it. Besides providing information regarding the key players within the Electroceuticals Bioelectric Medicine market, the study also recalibrates, the impact of macroeconomic and microeconomic factors that has the potent
Show less
Read more
Impact Snapshot
Event Time:
NVRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVRO alerts
High impacting Nevro Corp. news events
Weekly update
A roundup of the hottest topics
NVRO
News
- Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024PR Newswire
- Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Royal Bank of Canada from $18.00 to $16.00. They now have a "sector perform" rating on the stock.MarketBeat
- Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Mizuho from $20.00 to $16.00. They now have a "neutral" rating on the stock.MarketBeat
- Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Wells Fargo & Company from $17.00 to $14.00. They now have an "equal weight" rating on the stock.MarketBeat
- Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Citigroup Inc. from $18.00 to $16.00. They now have a "neutral" rating on the stock.MarketBeat
NVRO
Earnings
- 2/21/24 - Beat
NVRO
Sec Filings
- 4/26/24 - Form 4
- 4/25/24 - Form 8-K
- 4/15/24 - Form 4
- NVRO's page on the SEC website